New Market Research Report: Other Musculoskeletal Disorders - Pipeline Review, H2 2012

Sept. 19, 2012 - PRLog -- Global Markets Direct's, 'Other Musculoskeletal Disorders - Pipeline Review, H2 2012', provides an overview of the Other Musculoskeletal Disorders therapeutic pipeline. This report provides information on the therapeutic development for Other Musculoskeletal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Musculoskeletal Disorders. 'Other Musculoskeletal Disorders - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/463776_other_musculoskeletal_d...
------------------------------------------------------------

Scope

* A snapshot of the global therapeutic scenario for Other Musculoskeletal Disorders.
* A review of the Other Musculoskeletal Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Other Musculoskeletal Disorders pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Other Musculoskeletal Disorders.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Other Musculoskeletal Disorders pipeline depth and focus of Other Musculoskeletal Disorders therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Other Musculoskeletal Disorders Therapeutic Products under Development, Key Players in Other Musculoskeletal Disorders Therapeutics, Other Musculoskeletal Disorders Pipeline Overview, Other Musculoskeletal Disorders Pipeline, Other Musculoskeletal Disorders Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Other Musculoskeletal Disorders Overview
Therapeutics Development
An Overview of Pipeline Products for Other Musculoskeletal Disorders
Other Musculoskeletal Disorders Therapeutics under Development by Companies
Other Musculoskeletal Disorders Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Other Musculoskeletal Disorders Therapeutics - Products under Development by Companies
Other Musculoskeletal Disorders Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Other Musculoskeletal Disorders Therapeutics Development
Osteologix, Inc.
Adocia
Other Musculoskeletal Disorders - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Epsilon-Aminocaproic Acid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
N-Acetylcysteine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Valproic Acid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Etanercept - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ibandronate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nutropin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Humatrope - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Growth Hormone-Releasing Hormone (GRH) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Folic Acid 0.4mg - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Folic Acid 4mg - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Aredia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Etanercept - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zoledronic acid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Wnt Activators - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Magnesium Chloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Immune Globulin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Somatropin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Methotrexate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Estrogen + Progesterone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bonviva - Drug Profile
Product Description
Mechanism of Action
R&D Progress

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=4637...

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.